Announced details
Healthcare and biopharmaceutical industries; investor communications
Conferences in which the company's consolidated subsidiary, Gyre Therapeutics, Inc., will participate and present. Gyre's NASDAQ ticker is GYRE.
Investor conferences attended by companies and institutional investors from the healthcare and biopharmaceutical industries, among others. The location is stated in the source as New York, United States. Details of the organizers are Not disclosed.
New York, United States (conference venue)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Gyre Therapeutics press release dated 3 September 2026
| Item | Details |
|---|---|
| Counterparty | Cantor Global Healthcare Conference、Morgan Stanley Healthcare Conference |
| Counterparty overview | Investor conferences attended by companies and institutional investors from the healthcare and biopharmaceutical industries, among others. The location is stated in the source as New York, United States. Details of the organizers are Not disclosed. |
| Relationship with the Company | Conferences in which the company's consolidated subsidiary, Gyre Therapeutics, Inc., will participate and present. Gyre's NASDAQ ticker is GYRE. |
| Launch date | Scheduled for 9 September 2026 (Wednesday) and 16 September 2026 (Wednesday) |
| Applicable area | Healthcare and biopharmaceutical industries; investor communications |
| Location | New York, United States (conference venue) |
| Source | Gyre Therapeutics press release dated 3 September 2026 |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Both conferences are investor conferences attended by companies and institutional investors from the healthcare and biopharmaceutical industries, among others.